CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
p-aminohippurate clearance study +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04482920
NCT04482920N/ACompleted

The Effects of Hormone Therapy on Renal Hemodynamic Function in Transgender Youth

University of Colorado, Denver·observational·Posted Jul 23, 2020·Updated May 3, 2024

In Brief

An observational study evaluating p-aminohippurate clearance study and Iohexol infusion for Transgenderism and 2 related conditions. Completed, enrolled 22 participants across 1 site.

Detailed Summary

The purpose of this study is to understand the effects of testosterone or estradiol on kidney function in transgender adolescents and young adults.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJul 23, 2020
Enrollment StartApr 15, 2021
Primary CompletionAug 31, 2023
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 5.9 years ago

Interventions

p-aminohippurate clearance studyother

To measure kidney blood flow, small doses of a substance called p-aminohippurate (PAH) are used.

Iohexol infusionother

To measure glomerular filtration rate (GFR)